WallStreetZenWallStreetZen

NASDAQ: PRE
Prenetics Global Ltd Stock

Open Broker Account
$1.81-0.03 (-1.63%)
Updated Dec 9, 2022
PRE Price
$1.81
Fair Value Price
$2.16
Market Cap
$200.87M
52 Week Low
$1.24
52 Week High
$10.94
P/E
-0.13x
P/B
0.97x
P/S
0.6x
PEG
N/A
Dividend Yield
N/A
Revenue
$441.84M
Earnings
-$358.34M
Gross Margin
42.7%
Operating Margin
-78.27%
Profit Margin
-81.1%
Debt to Equity
0.3
Operating Cash Flow
N/A
Beta
0.41
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PRE Overview

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Zen Score

Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRE ($1.81) is undervalued by 16.32% relative to our estimate of its Fair Value price of $2.16 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PRE ($1.81) is not significantly undervalued (16.32%) relative to our estimate of its Fair Value price of $2.16 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PRE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRE due diligence checks available for Premium users.

Be the first to know about important PRE news, forecast changes, insider trades & much more!

Valuation

PRE fair value

Fair Value of PRE stock based on Discounted Cash Flow (DCF)
Price
$1.81
Fair Value
$2.16
Undervalued by
16.32%
PRE ($1.81) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRE ($1.81) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.13x
Industry
36x
Market
21.21x

PRE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.97x
Industry
4.36x
PRE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRE's financial health

Profit margin

Revenue
$79.7M
Net Income
-$14.9M
Profit Margin
-18.7%
PRE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$269.6M
Liabilities
$62.3M
Debt to equity
0.3
PRE's short-term assets ($250.09M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRE's short-term assets ($250.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A

PRE vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
PRE$200.87M-1.84%-0.13x0.97x
BVS$200.57M-2.64%-1.25x0.58x
STIM$174.49M+3.39%-4.71x2.77x
NOTV$145.37M+3.65%N/A0.24x
CELC$145.01M-1.68%-3.94x3.33x

Prenetics Global Stock FAQ

What is Prenetics Global's quote symbol?

NASDAQ: PRE) Prenetics Global trades on the NASDAQ under the ticker symbol PRE. Prenetics Global stock quotes can also be displayed as NASDAQ: PRE.

If you're new to stock investing, here's how to buy Prenetics Global stock.

What is the 52 week high and low for Prenetics Global (NASDAQ: PRE)?

(NASDAQ: PRE) Prenetics Global's 52-week high was $10.94, and its 52-week low was $1.24. It is currently -83.46% from its 52-week high and 45.97% from its 52-week low.

How much is Prenetics Global stock worth today?

(NASDAQ: PRE) Prenetics Global currently has 110,979,347 outstanding shares. With Prenetics Global stock trading at $1.81 per share, the total value of Prenetics Global stock (market capitalization) is $200.87M.

Prenetics Global stock was originally listed at a price of $9.96 in May 14, 2021. If you had invested in Prenetics Global stock at $9.96, your return over the last 1 years would have been -81.83%, for an annualized return of -81.83% (not including any dividends or dividend reinvestments).

How much is Prenetics Global's stock price per share?

(NASDAQ: PRE) Prenetics Global stock price per share is $1.81 today (as of Dec 9, 2022).

What is Prenetics Global's Market Cap?

(NASDAQ: PRE) Prenetics Global's market cap is $200.87M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Prenetics Global's market cap is calculated by multiplying PRE's current stock price of $1.81 by PRE's total outstanding shares of 110,979,347.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.